Witteck, Andrea; Schmid, Patrick; Hensel-Koch, Katharina; Thurnheer, Maria C; Bruggmann, Philip; Vernazza, Pietro; Swiss Hepatitis C and HIV Cohort Studies, (2011). Management of hepatitis C virus (HCV) infection in drug substitution programs. Swiss medical weekly, 141, w13193. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13193
Full text not available from this repository. (Request a copy)In Switzerland, intravenous drug use (IDU) accounts for 80% of newly acquired hepatitis C virus (HCV) infections. Early HCV treatment has the potential to interrupt the transmission chain and reduce morbidity/mortality due to decompensated liver cirrhosis and hepatocellular carcinoma. Nevertheless, patients in drug substitution programs are often insufficiently screened and treated.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology |
UniBE Contributor: |
Thurnheer Zürcher, Maria Christine |
ISSN: |
1424-7860 |
Publisher: |
EMH Schweizerischer Ärzteverlag |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:24 |
Last Modified: |
05 Dec 2022 14:07 |
Publisher DOI: |
10.4414/smw.2011.13193 |
PubMed ID: |
21623473 |
Web of Science ID: |
000291025600001 |
URI: |
https://boris.unibe.ch/id/eprint/8276 (FactScience: 213793) |
Actions (login required)
 |
Edit item |